clinical trial · NCT03669757
Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis
LEO Pharma·phase1·completed·n = 13
Psoriasis VulgarisLEO 134310LEO 134310LEO 134310LEO 134310LEO 134310 vehicle0.1% betamethasone valerate ointment (class III steroid)
brief summary
To assess safety and tolerability after treatment with LEO 134310 cutaneous solution.
started
Sep 27, 2018
primary completion
Feb 1, 2019
completion
Feb 1, 2019
last updated
Oct 26, 2024
official title
A Phase 1b, Randomised, Controlled, Observer-blinded Trial to Assess Safety, Tolerability and Pharmacodynamic Effects of LEO 134310 Cutaneous Solution in Descaled Skin of Adults With Chronic Plaque Psoriasis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol